PAM
AGRX

Panagora Asset Management’s Agile Therapeutics AGRX Stock Holding History

Panagora Asset Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$9K – 3030
2021
Q1 		$9K Hold
2
– – ﹤0.01% 2456
2020
Q4 		$12K Hold
2
– – ﹤0.01% 2270
2020
Q3 		$13K Buy
+2
New +$11.5K ﹤0.01% 2288
2019
Q4 		– Sell
-1
Closed -$2K – 2611
2019
Q3 		$2K Buy
+1
New +$2.46K ﹤0.01% 2380
2019
Q2 		– Hold
0
– – – 2581
2018
Q4 		– Sell
-46
Closed -$34K – 2554
2018
Q3 		$34K Buy
46
+36
+360% +$26.4K ﹤0.01% 2113
2018
Q2 		$10K Hold
10
– – ﹤0.01% 2269
2018
Q1 		$50K Buy
10
+2
+25% +$13.2K ﹤0.01% 2034
2017
Q4 		$45K Buy
+8
New +$74.5K ﹤0.01% 2065

Other funds holding AGRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's AGRX Position: Q2 2021 in Review

Panagora Asset Management sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 2 shares — an estimated $9K sold.

Panagora Asset Management first reported a position in AGRX in Q4 2017 and held it in 8 quarters. The position peaked at $50K in Q1 2018. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

  • Panagora Asset Management reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Panagora Asset Management sold 2 Agile Therapeutics shares in Q2 2021, an estimated $9K.
  • Panagora Asset Management first reported a position in Agile Therapeutics in Q4 2017 and held it in 8 quarters.
  • Panagora Asset Management's Agile Therapeutics position peaked at $50K in Q1 2018.
  • 64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on Panagora Asset Management's 13F filing for Q2 2021, filed 11 Aug 2021.